Plato Investment Management Ltd Takes $207,000 Position in Doximity, Inc. (NASDAQ:DOCS)

Plato Investment Management Ltd acquired a new position in shares of Doximity, Inc. (NASDAQ:DOCS) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 3,871 shares of the company’s stock, valued at approximately $207,000.

Other institutional investors also recently added to or reduced their stakes in the company. SBI Securities Co. Ltd. purchased a new position in Doximity in the fourth quarter worth $4,207,000. West Michigan Advisors LLC acquired a new stake in shares of Doximity in the fourth quarter worth $306,000. US Bancorp DE raised its stake in shares of Doximity by 7.8% during the 4th quarter. US Bancorp DE now owns 11,285 shares of the company’s stock valued at $603,000 after buying an additional 818 shares during the last quarter. Fielder Capital Group LLC raised its position in Doximity by 4.5% during the fourth quarter. Fielder Capital Group LLC now owns 5,488 shares of the company’s stock valued at $293,000 after acquiring an additional 235 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. increased its holdings in shares of Doximity by 13.1% during the 4th quarter. Oppenheimer Asset Management Inc. now owns 19,075 shares of the company’s stock valued at $1,018,000 after purchasing an additional 2,212 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

Doximity Price Performance

Doximity stock opened at $67.78 on Wednesday. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21. The stock’s 50-day moving average is $62.30 and its 200-day moving average is $51.18. The company has a market cap of $12.65 billion, a price-to-earnings ratio of 67.78, a price-to-earnings-growth ratio of 4.10 and a beta of 1.39.

Insider Buying and Selling at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now owns 6,360 shares in the company, valued at $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 37.40% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on DOCS shares. Barclays lifted their price target on Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a research note on Monday, November 11th. Leerink Partners raised shares of Doximity from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $60.00 to $90.00 in a research note on Friday, February 7th. JPMorgan Chase & Co. lifted their price objective on Doximity from $30.00 to $48.00 and gave the stock a “neutral” rating in a research report on Thursday, November 21st. Canaccord Genuity Group boosted their target price on shares of Doximity from $60.00 to $71.00 and gave the company a “hold” rating in a report on Friday, February 7th. Finally, Bank of America upped their price target on Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research note on Monday, January 6th. Eleven investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, Doximity presently has an average rating of “Moderate Buy” and a consensus price target of $64.22.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.